CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 122 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,168,899 | +95.1% | 106,554 | +18.2% | 0.00% | +100.0% |
| Q2 2023 | $1,624,575 | +123441.8% | 90,154 | +10.1% | 0.00% | 0.0% |
| Q1 2023 | $1,315 | -9.0% | 81,904 | +3.7% | 0.00% | 0.0% |
| Q4 2022 | $1,445 | -99.9% | 78,988 | -0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,551,000 | +13.0% | 78,995 | +7.4% | 0.00% | 0.0% |
| Q2 2022 | $1,372,000 | +31.0% | 73,556 | +54.2% | 0.00% | +100.0% |
| Q1 2022 | $1,047,000 | -14.4% | 47,701 | +10.8% | 0.00% | 0.0% |
| Q4 2021 | $1,223,000 | +64.2% | 43,047 | +21.6% | 0.00% | 0.0% |
| Q3 2021 | $745,000 | +17.9% | 35,403 | +5.5% | 0.00% | 0.0% |
| Q2 2021 | $632,000 | +45.6% | 33,551 | +18.1% | 0.00% | 0.0% |
| Q1 2021 | $434,000 | 0.0% | 28,397 | -7.7% | 0.00% | 0.0% |
| Q4 2020 | $434,000 | -1.1% | 30,767 | +9.9% | 0.00% | 0.0% |
| Q3 2020 | $439,000 | -23.3% | 27,987 | -14.3% | 0.00% | 0.0% |
| Q2 2020 | $572,000 | +205.9% | 32,657 | +157.2% | 0.00% | – |
| Q1 2020 | $187,000 | -41.4% | 12,698 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $319,000 | +67.9% | 12,698 | +0.6% | 0.00% | – |
| Q3 2019 | $190,000 | -40.4% | 12,626 | -1.0% | 0.00% | -100.0% |
| Q2 2019 | $319,000 | +43.0% | 12,751 | +30.4% | 0.00% | – |
| Q1 2019 | $223,000 | -12.2% | 9,776 | +15.4% | 0.00% | -100.0% |
| Q4 2018 | $254,000 | – | 8,475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,030,616 | $31,028,000 | 6.04% |
| 5AM Venture Management, LLC | 1,362,286 | $20,816,000 | 3.75% |
| Burrage Capital Management LLC | 272,393 | $4,162,000 | 3.37% |
| Altium Capital Management LP | 361,930 | $5,530,000 | 1.54% |
| Vivo Capital, LLC | 2,214,138 | $33,832,000 | 1.19% |
| Bain Capital Life Sciences Investors, LLC | 1,071,428 | $16,371,000 | 0.93% |
| Perceptive Advisors | 3,659,381 | $51,606,000 | 0.65% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,154,000 | 0.50% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,003,688 | $30,616,000 | 0.45% |
| Opaleye Management Inc. | 188,000 | $2,873,000 | 0.42% |